Smartwatch-Style BP monitor put to the test against standard cuff
NCT ID NCT07633886
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This study tests a medical wrist device called the Corsano CardioWatch 287-2 that measures blood pressure. Researchers will compare its readings to standard arm-cuff measurements in 170 adults over 31 days. The goal is to see if the device works accurately for home monitoring across different ages and backgrounds.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD PRESSURE MONITORING, AMBULATORY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Corsano CardioWatch 287-2 wearable blood pressure monitor
What this could lead to
If successful, this could provide a reliable way for people to monitor their blood pressure at home using a wrist device, making tracking easier and more convenient.
What could go wrong
This is an early-stage validation study with only 170 participants. The device may not be as accurate as standard cuffs for all users, and results may not apply to everyone.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.